Status:
UNKNOWN
MR-Lymphography and Lymph Node Staging in Prostate Cancer
Lead Sponsor:
Radboud University Medical Center
Collaborating Sponsors:
ZonMw: The Netherlands Organisation for Health Research and Development
Conditions:
Prostatic Neoplasms
Lymphatic Metastasis
Eligibility:
MALE
18+ years
Phase:
PHASE4
Brief Summary
This proposal is targeted at all patients with prostate cancer who are candidates for either curative surgery or curative radiotherapy in whom lymph node staging is indicated. Recently, it has been sh...
Detailed Description
Objective(s) of the proposed study The first objective of this study is to evaluate whether MRL can replace currently used nodal staging techniques such as CT-scanning and PLND in patients with prosta...
Eligibility Criteria
Inclusion
- prostate cancer
- PSA \> 10 or Gleason \> 6 or T3 tumor
- adult male
- scheduled for lymphadenectomy
- written informed consent
Exclusion
- Patient having undergone chemotherapy or radiotherapy of the pelvic area
- patient having undergone resection of the pelvic tumor with lymphadenectomy
- Patient included in another trial involving an investigational drug
Key Trial Info
Start Date :
April 1 2002
Trial Type :
INTERVENTIONAL
End Date :
August 1 2005
Estimated Enrollment :
396 Patients enrolled
Trial Details
Trial ID
NCT00185029
Start Date
April 1 2002
End Date
August 1 2005
Last Update
September 16 2005
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
NKI AVL
Amsterdam, Netherlands, 1066 CX
2
Catharina Hospital
Eindhoven, Netherlands, 5602 ZA
3
Ziekenhuis Zeeuws-Vlaanderen
Terneuzen, Netherlands, 4535 PA